Sara Yin

Sara Yin has a diverse work experience spanning multiple industries and roles. Sara began their career as an intern at AVEO Pharmaceuticals in 2011, followed by roles at bioMerieux and Quintiles. In 2012, they joined Simon-Kucher & Partners as a Consultant, specializing in Marketing and Sales Strategies. Sara then transitioned to Biogen as a Senior Manager, focusing on Global Market Access.

Sara's career continued to progress with positions at EMD Serono, Inc., where they held several director-level roles within US Market Access and Customer Solutions. Sara was responsible for leading the US launch of MAVENCLAD, overseeing access strategy development, and successfully negotiating value-based contracts with major corporate accounts.

In 2020, Sara joined Epizyme as a Senior Director, leading Access Marketing and New Product Planning. Sara played a key role in developing access strategies and ensuring their execution through training and coaching.

Most recently, Sara became the Senior Director of Market Access Strategy & Operations at Collegium Pharmaceutical, Inc. in 2023. Sara'sexpertise in market access and strategy will contribute to the company's success.

Sara Yin has an MBA with a focus on Strategy, Marketing & Sales, and Healthcare management from the MIT Sloan School of Management. Sara also holds a Ph.D. in Pharmacology from Vanderbilt University and a B.S. in Genetics and Genetic Engineering from Fudan University. In addition to their degrees, Sara has obtained several certifications including a Diploma for Basic Spanish from MAXIMO NIVEL in February 2023, a Certificate in Drug and Medical Device Development: A strategic Approach from MIT xPRO in June 2022, a Certificate in Digital Marketing from Cornell University in September 2020, and a Certificate in Health Economics and Outcomes Research from the University of Washington in June 2016.